Page last updated: 2024-08-23

phosphotyrosine and tamoxifen

phosphotyrosine has been researched along with tamoxifen in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karthikeyan, N; Thampan, RV1
Bartholomew, PJ; DePasquale, JA; Vinci, JM1
Kokunai, T; Liu, Z; Tamaki, N1
Cameron, DA; Hasmann, M; Langdon, SP; Mullen, P; Smyth, JF1
Bernaciak, TM; Fox, EM; Shupnik, MA; Silva, CM; Weaver, AM; Wen, J1

Other Studies

5 other study(ies) available for phosphotyrosine and tamoxifen

ArticleYear
Plasma membrane is the primary site of localization of the nonactivated estrogen receptor in the goat uterus: hormone binding causes receptor internalization.
    Archives of biochemistry and biophysics, 1996, Jan-01, Volume: 325, Issue:1

    Topics: Animals; Biological Transport; Cell Fractionation; Cell Membrane; Dexamethasone; Diethylstilbestrol; Estradiol; Female; Goats; Immunoblotting; Phosphorylation; Phosphotyrosine; Progesterone; Protein-Tyrosine Kinases; Receptors, Estrogen; Tamoxifen; Testosterone; Uterus

1996
Decreased tyrosine phosphorylation of focal adhesion kinase after estradiol treatment of MCF-7 human breast carcinoma cells.
    The Journal of steroid biochemistry and molecular biology, 1998, Volume: 67, Issue:3

    Topics: Breast Neoplasms; Cell Adhesion; Cell Adhesion Molecules; Cytoskeletal Proteins; Dimethyl Sulfoxide; Estradiol; Female; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Paxillin; Phosphoproteins; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured; Tyrosine

1998
Tamoxifen interacts with NEU/C-ERBB-2 receptor and inhibits growth of human malignant glioma cell lines.
    The Kobe journal of medical sciences, 2001, Volume: 47, Issue:3

    Topics: Cell Division; DNA; Estrogen Antagonists; Glioblastoma; Humans; Immunoblotting; Immunosorbent Techniques; Phosphorylation; Phosphotyrosine; Receptor, ErbB-2; Tamoxifen; Tumor Cells, Cultured

2001
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:1

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Enzyme Activation; Estrogens; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Neuregulin-1; Ovarian Neoplasms; Phosphorylation; Phosphotyrosine; Receptor Cross-Talk; Receptor, ErbB-2; Receptors, Estrogen; Signal Transduction; Tamoxifen; Transforming Growth Factor alpha

2007
Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Molecular endocrinology (Baltimore, Md.), 2008, Volume: 22, Issue:8

    Topics: Breast Neoplasms; Cell Count; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Drug Resistance, Neoplasm; ErbB Receptors; Estradiol; Estrogen Receptor alpha; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Phosphorylation; Phosphotyrosine; Proto-Oncogene Proteins pp60(c-src); Signal Transduction; STAT5 Transcription Factor; Tamoxifen; Transcription, Genetic

2008